Case Study 1 – Expanding in India, staying ahead of the curve; How ODINT help British drug supplier ace to the Indian market.

  • Home
  • Case Study 1 – Expanding in India, staying ahead of the curve; How ODINT help British drug supplier ace to the Indian market.
Data Driven Transformation

Background

A leading British drug quality affirmation specialist organization saw a huge blockade in customer inquiries from India during the COVID 19 pandemic. Since Indian drug manufacturers are situated very well to supply medicine like HCQC hydroxychloroquine and vaccinations to the rest of the world, they require quality certificates like GMP/great assembling practices and FDA/Food Drug Association certificate to fare to nations in North America.

Challenge

The British specialist was utilizing third-party advisors from India to send to the patron site to give quality assurance consulting services. Due to the GST/products and service tax charge system in India. The organization was losing 18% of taxes imposed on expert administrations on international companies.

AI ML

The FUTURE is here

Enterprises that use AI are more equipped to handle the challenges of the evolving world.

How Did We Help ?

1. Simplicity

The specialist was convinced with the lucidity given by ODINT’s Indian market entry consultant.

Our expert team gave the total extent of administration from FTI organizing, subsidiary formation, central bank, or RBI clearances.

2. Legal Requirements

3. Documentation
&
Process

Alongside all documentation work including yet not restricted to opening up a local bank account, getting GST number to PAN to set up local billing

Within 4 months of their market entry in India, the organization has effectively saved thousands of dollars from extra weight 18% GST.

4. Timeframe

5. Output

Aside from this, it also helped them to approach new clients in the ever-growing Indian pharmaceutical marketplace with more confidence in a local presence.

Make your business AI-Ready
Company Profile
Download Proposal
Asia:+91-9643-460-171 Europe:+31-(0)20-244-1878